Consensus Evotec SE

Equities

Market Closed - Xetra Other stock markets 16:35:25 18/07/2025 BST			5-day change	1st Jan Change
7.456 ^EUR	+0.59%		+5.82%	-9.02%

07-09	EVOTEC : Deutsche Bank reiterates its Neutral rating	ZD
06-26	EVOTEC : Warburg Research remains its Buy rating	ZD

b6517f709a72.q9wqOQ67VETdHX5v-EMhUUQtir0c_RkwHX9z4LYR8go.mLBzDmHWNQG2aBIZlC9POAd1899eiSxqaCcVrsxzqnD6mUZwPIoTF-xTPw~1b73d8bd7a3362eb3bbe15d1a489cd4c

EVOTEC : Deutsche Bank reiterates its Neutral rating	07-09	ZD
EVOTEC : Warburg Research remains its Buy rating	06-26	ZD
EVOTEC : Warburg Research reiterates its Buy rating	06-17	ZD
EVOTEC : RBC reiterates its Buy rating	05-15	ZD
EVOTEC : Deutsche Bank gives a Neutral rating	05-07	ZD
EVOTEC : Warburg Research keeps its Buy rating	05-06	ZD
RBC leaves Evotec at 'Outperform' - target €11.60	05-06	DP
Evotec very weak after quarterly figures	05-06	DP
EVOTEC : Receives a Buy rating from RBC	05-06	ZD
Deutsche Bank Research raises Evotec to 'Hold' and target price to €7	04-24	DP
EVOTEC : Upgraded to Neutral by Deutsche Bank	04-24	ZD
Warburg Research lowers target for Evotec to €12.10 – 'Buy'	04-23	DP
EVOTEC : Warburg Research reiterates its Buy rating	04-23	ZD
EVOTEC : Gets a Buy rating from Warburg Research	04-17	ZD
EVOTEC : RBC reiterates its Buy rating	04-17	ZD
Investors reward Evotec's longer-term outlook	04-17	DP
EVOTEC : RBC remains its Buy rating	03-28	ZD
EVOTEC : Deutsche Bank keeps a Sell rating	03-03	ZD
EVOTEC : Gets a Buy rating from Warburg Research	02-03	ZD
EVOTEC : Warburg Research keeps its Buy rating	12-12	ZD
EVOTEC : Gets a Sell rating from Deutsche Bank	11-25	ZD
EVOTEC : RBC reiterates its Buy rating	11-22	ZD
EVOTEC : Deutsche Bank reiterates its Sell rating	11-18	ZD
EVOTEC : Warburg Research remains its Buy rating	11-15	ZD
Jefferies rates Evotec at 'Hold' - Target 6.80 Euro	11-15	DP

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus (Composite)	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Ecart obj. / dr
	EVOTEC SE					+44.36%
	LONZA GROUP AG					+16.77%
	BEONE MEDICINES LTD.					+15.53%
	CELLTRION, INC.					+19.73%
	IQVIA HOLDINGS INC.					+16.8%
	EUROFINS SCIENTIFIC SE					-0.4%
	ICON PUBLIC LIMITED COMPANY					+19.83%
	ASCENDIS PHARMA A/S					+32.78%
	TEMPUS AI, INC.					+10.1%
	QIAGEN N.V.					+4.83%
	Average					+18.03%
	Weighted average by Cap.					+16.11%

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

7.456EUR

Average target price

10.70EUR

Spread / Average Target

+43.51%

High Price Target

22.00EUR

Spread / Highest target

+195.06%

Low Price Target

7.000EUR

Spread / Lowest Target

-6.12%